Skip to main content

Complications, Postoperative

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Spine BioPharma
Spine BioPharmaNY - New York
1 program
DrainN/A1 trial
Active Trials
NCT06820736Recruiting975Est. Jan 2040
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Laparoscopic D2 distal gastrectomyN/A1 trial
Active Trials
NCT03468712Unknown166Est. Apr 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Spine BioPharmaDrain
UNION therapeuticsLaparoscopic D2 distal gastrectomy

Clinical Trials (2)

Total enrollment: 1,141 patients across 2 trials

A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion

Start: Jan 2025Est. completion: Jan 2040975 patients
N/ARecruiting
NCT03468712UNION therapeuticsLaparoscopic D2 distal gastrectomy

Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers

Start: Mar 2018Est. completion: Apr 2023166 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 1,141 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.